Literature DB >> 30614551

Hormonal and metabolic effects of carbohydrate restriction in children with Prader-Willi syndrome.

Krystal A Irizarry1, Diana R Mager2, Lucila Triador3, Michael J Muehlbauer4, Andrea M Haqq3, Michael Freemark1,4.   

Abstract

OBJECTIVE: Macronutrient regulation of hyperphagia and adiposity in Prader-Willi syndrome (PWS) is poorly understood. We compared fasting and postprandial concentrations of hormones and metabolites in eight PWS children (age 9-18 years) fed, in random order, low carbohydrate, high-fat (LC, 15% carb; 65% fat; 20% protein) and low-fat, high carbohydrate (LF, 65% carb, 15% fat, 20% protein) diets matched for calories and protein.
METHODS: Participants were randomized to consume either the LC or LF diet during a first hospital admission and the second diet during a subsequent admission. Blood samples were obtained after overnight fasting and 1 hour after a mixed meal.
RESULTS: Relative to subjects consuming the LF diet, subjects consuming the LC diet had: lower postprandial insulin concentrations (P = 0.02); higher fasting GLP-1 AND GIP concentrations and increased postprandial GLP-1 (P < 0.02); reduced ratio of fasting ghrelin to GLP-1 (P = 0.0078); increased FFA and fatty acid oxidation, as assessed by concentrations of even-chain acylcarnitines (P < 0.001); lower fasting TG and TG/HDL ratio (P < 0.01); and higher concentrations of branch chain amino acids (P < 0.01). There were no changes in glucose, PYY, or adiponectin. CRP, AST and ALT were all higher (P < 0.01) on the LC diet.
CONCLUSIONS: Increases in GLP-1 with low carbohydrate feeding and reductions in the ratio of ghrelin to GLP-1 might limit food intake and improve glycaemic control in PWS. Other potential benefits of carbohydrate restriction may include fat mobilization and oxidation and reductions in the TG/HDL ratio, a marker of insulin resistance. However, increases in CRP, AST and ALT necessitate longer-term studies of low carbohydrate efficacy and safety.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  GIP, insulin; GLP-1; PYY; Prader-Willi syndrome; branch chain amino acids; ghrelin; low carbohydrate diet

Mesh:

Substances:

Year:  2019        PMID: 30614551      PMCID: PMC6805129          DOI: 10.1111/cen.13933

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  32 in total

1.  A clinical note on food preference of individuals with Prader-Willi syndrome: the need for empirical research.

Authors:  M L Caldwell; R L Taylor
Journal:  J Ment Defic Res       Date:  1983-03

2.  Ghrelin enhances appetite and increases food intake in humans.

Authors:  A M Wren; L J Seal; M A Cohen; A E Brynes; G S Frost; K G Murphy; W S Dhillo; M A Ghatei; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

Review 3.  A review of chemosensory perceptions, food preferences and food-related behaviours in subjects with Prader-Willi Syndrome.

Authors:  Lorelei Martínez Michel; Andrea M Haqq; Wendy V Wismer
Journal:  Appetite       Date:  2015-12-20       Impact factor: 3.868

4.  Hormonal and metabolic responses to endurance exercise in children with Prader-Willi syndrome and non-syndromic obesity.

Authors:  Daniela A Rubin; Susan J Clark; Jason Ng; Diobel M Castner; Andrea M Haqq; Daniel A Judelson
Journal:  Metabolism       Date:  2014-12-02       Impact factor: 8.694

5.  Incretin hormone and insulin responses to oral versus intravenous lipid administration in humans.

Authors:  Ola Lindgren; Richard D Carr; Carolyn F Deacon; Jens J Holst; Giovanni Pacini; Andrea Mari; Bo Ahrén
Journal:  J Clin Endocrinol Metab       Date:  2011-05-18       Impact factor: 5.958

6.  The Study of the Effects of Diet on Metabolism and Nutrition (STEDMAN) weight loss project: Rationale and design.

Authors:  Andrea M Haqq; Lillian F Lien; Jarol Boan; Michelle Arlotto; Cris A Slentz; Michael J Muehlbauer; James Rochon; Dianne Gallup; Ross L McMahon; James R Bain; Robert Stevens; David Millington; Mark D Butler; Christopher B Newgard; Laura P Svetkey
Journal:  Contemp Clin Trials       Date:  2005-10-18       Impact factor: 2.226

7.  Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB(0,+).

Authors:  Sonne R Srinivas; Puttur D Prasad; Nagavedi S Umapathy; Vadivel Ganapathy; Prem S Shekhawat
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-09-13       Impact factor: 4.052

8.  An investigation into food preferences and the neural basis of food-related incentive motivation in Prader-Willi syndrome.

Authors:  E C Hinton; A J Holland; M S N Gellatly; S Soni; A M Owen
Journal:  J Intellect Disabil Res       Date:  2006-09

9.  The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism.

Authors:  Gary Frost; Michelle L Sleeth; Meliz Sahuri-Arisoylu; Blanca Lizarbe; Sebastian Cerdan; Leigh Brody; Jelena Anastasovska; Samar Ghourab; Mohammed Hankir; Shuai Zhang; David Carling; Jonathan R Swann; Glenn Gibson; Alexander Viardot; Douglas Morrison; E Louise Thomas; Jimmy D Bell
Journal:  Nat Commun       Date:  2014-04-29       Impact factor: 14.919

10.  A special, strict, fat-reduced, and carbohydrate-modified diet leads to marked weight reduction even in overweight adolescents with Prader-Willi syndrome (PWS).

Authors:  Walter Bonfig; Kathi Dokoupil; Heinrich Schmidt
Journal:  ScientificWorldJournal       Date:  2009-09-14
View more
  2 in total

Review 1.  Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.

Authors:  Éva Erhardt; Dénes Molnár
Journal:  Nutrients       Date:  2022-05-06       Impact factor: 6.706

Review 2.  Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.

Authors:  G Muscogiuri; L Barrea; F Faggiano; M I Maiorino; M Parrillo; G Pugliese; R M Ruggeri; E Scarano; S Savastano; A Colao
Journal:  J Endocrinol Invest       Date:  2021-04-23       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.